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The promising potential of magnetic polymer microspheres in various biomedical applications has 
been frequently reported. However, the surface hydrophilicity of superparamagnetic iron oxide 
nanoparticles (SPIONs) usually leads to poor or even failed encapsulation of SPIONs in hydrophobic 
polymer microspheres using the emulsion method. In this study, the stability of SPIONs in poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) solution was significantly increased after surface 
modification with lauric acid. As a result, magnetic PHBV microspheres with high encapsulation 
efficiencies (71.0–87.4%) were prepared using emulsion-solvent extraction/evaporation method. 
Magnetic resonance imaging (MRI) showed significant contrast for the magnetic PHBV microspheres. 
The toxicity of these magnetic PHBV microspheres towards human T-lymphoma suspension cells and 
adherent colon carcinoma HT-29 cells was investigated using flow cytometry, and they were shown 
to be non-toxic in a broad concentration range. A model drug, tetracycline hydrochloride, was used to 
demonstrate the drug delivery capability and to investigate the drug release behavior of the magnetic 
PHBV microspheres. The drug was successfully loaded into the microspheres using lauric acid-coated 
SPIONs as drug carrier, and was released from the microspheres in a diffusion controlled manner. The 
developed magnetic PHBV microspheres are promising candidates for biomedical applications such as 
targeted drug delivery and MRI.
Magnetic polymer microspheres have attracted increasing attention and are being widely used in biomedical 
fields such as drug delivery1–4, magnetic resonance imaging (MRI)2–6, bio-separation7,8, enzyme immobilization9, 
hyperthermia therapy10 as well as water treatment11. Particularly, magnetic polymer microspheres have the advan-
tage of being readily multifunctional, such as enabling the targeted drug delivery procedure being monitored by 
MRI2,3,12. Magnetically targeted drug delivery has emerged as a promising strategy to deliver drugs to the site of 
interest using an external magnetic field1–3,13. Local drug concentrations can be enhanced over 50-fold compared 
to standard intravenous application14. Therefore, in this superior drug delivery system, the amount of circulating 
drug can be reduced by the control of magnetically targeted drug, reducing toxicity and side effects after systemic 
administration. Moreover, when polymer microspheres are used for magnetic targeted drug delivery, the polymer 
matrix has the potential to protect the drug from degradation.
The success of these technologies using magnetic microspheres greatly depends on their preparation from 
biocompatible and biodegradable polymers of either synthetic2,8,15–17 or natural origin3,12,18. To date, magnetic 
polymer microspheres have been prepared by various methods, such as emulsion-solvent extraction/evapora-
tion2,15,19, spray drying1, electrospraying17, polymerization8 and microfluidics3, which feature partly competing 
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and partly complementary characteristics. Among these methods, the emulsion-solvent extraction/evaporation 
method possesses significant competitive advantages including good reproducibility and high degree of control 
over particle characteristics such as particle size, which make it one of the most popular methods to produce 
microspheres20,21.
Iron oxide nanoparticles, the only Food and Drug Administration (FDA)- and European Medicines Agency 
(EMA)-approved metal oxide nanoparticles, have attracted tremendous attention in targeted drug delivery, MRI 
and hyperthermia therapy13. The surface hydrophilicity of iron oxide nanoparticles enables them to be efficiently 
encapsulated by hydrophilic polymers, which in most cases are natural derived polymers3,11,18. However, the 
hydrophilic iron oxide nanoparticles strongly tend to partition into the external aqueous phase during emulsifica-
tion, which leads to great loss of iron oxide nanoparticles or even failure in preparing hydrophobic polymer-based 
magnetic microspheres2,15. Most of the hydrophobic polymers are synthetic derived. Compared to natural pol-
ymers, synthetic polymers often offer better control of physicochemical properties22. Obviously, a good stability 
of iron oxide nanoparticles in hydrophobic polymer solutions is a prerequisite to the successful fabrication and 
expanding application of magnetic polymer microspheres. Surface modification with fatty acids has been shown 
to improve the stability of iron oxide nanoparticles in dichloromethane (DCM)23, which is a typical organic sol-
vent used to dissolve hydrophobic polymers.
In the present study, superparamagnetic iron oxide nanoparticles (SPIONs) were surface modified with lauric 
acid, which belongs to the family of fatty acid. It was hypothesized that lauric acid could enable the SPIONs to be 
stable in hydrophobic polymer solution, and therefore facilitate the successful preparation of magnetic polymer 
microspheres with high encapsulation efficiency/loading efficiency using emulsion-solvent extraction/evapora-
tion method. Lauric acid was used in the present study also because the derived lauric acid-modified SPIONs 
have great potential for magnetic drug targeting, as shown in a previous study14,24. Poly(3-hydroxybutyrate-co-
3-hydroxyvalerate) (PHBV), which belongs to the class of polyhydroxyalkanoates (PHAs), is a promising bio-
technology derived hydrophobic polymer used for biomedical applications due to its biocompatibility, nontoxic 
and tailorable biodegradability25,26. In addition, unlike poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) 
(PLGA), PHBV does not produce acidic degradation products which may be harmful for human tissues, and it 
degrades into its monomers in vivo which are normal in the blood27.
In the first part of this investigation, SPIONs were surface modified with lauric acid, and then encapsulated 
into PHBV microspheres using solid-in-oil-in-water (S/O/W) emulsion-solvent extraction/evaporation method. 
The physicochemical properties and in vitro biocompatibility of the prepared magnetic PHBV microspheres were 
investigated. It should be pointed out that although various types of magnetic polymer microspheres have been 
developed1–3,8,11,15–17,19, only few in vitro or in vivo studies have been reported on these systems1–4. Thus, there is 
a strong demand to understand the biocompatibility of magnetic polymer microspheres, and the influence that 
polymer encapsulation may have on the toxicity of SPIONs. PHAs based-magnetic particles (from nm to mm size 
range) have only been reported recently28,29, and their biocompatibility has not been investigated yet to the best 
of our knowledge. Furthermore, in the present study, tetracycline hydrochloride (TCH), a widely used antibiotic, 
was chosen as a model of water-soluble drugs to demonstrate the drug delivery capability and to investigate the 
drug release behavior of the magnetic PHBV microspheres in vitro.
Results and Discussion
Surface modification on SPIONs0. The Fourier transform infrared spectroscopy (FTIR) spectra of the 
two investigated iron oxide nanoparticles SPIONs0 (without any coating) and SPIONsLA (with lauric acid coat-
ing) are shown in Fig. 1. The characteristic band of Fe–O stretching vibration was observed at 584 cm−1 for both 
SPIONs0 and SPIONsLA16,24. All the labelled bands of SPIONsLA except 584 cm−1, 1541 cm−1 and 1575 cm−1 belong 
to lauric acid24,30. In addition, compared to the other bands of (free) lauric acid, the band at 1708 cm−1 which 
belongs to carboxylic acid groups was relatively weak in SPIONsLA, and new bands at 1541 cm−1 and 1575 cm−1, 
Figure 1. FTIR spectra of SPIONs before (SPIONs0) and after (SPIONsLA) surface modification with lauric 
acid. (The different relevant peaks are explained in the text).
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which were attributed to carboxylate groups, appeared in SPIONsLA31,32. The appearance of carboxylate groups 
as well as weakened carboxylic groups indicates that chemical bonds formed between lauric acid and iron oxide 
nanoparticles30,32. Therefore, it is confirmed that lauric acid has been successfully coated on SPIONs0.
SPIONsLA are quite homogeneous as shown by the transmission electron microscopy (TEM) image (Fig. 2(a)). 
The diameter of the iron oxide cores was 11 ± 1 nm, which is much smaller than the superparamagnetic critical 
size (20 nm) of Fe3O4 nanoparticles33. At a higher magnification (Fig. 2(b)), lattice planes of individual particles 
are visible. The small and homogeneous particle size of SPIONsLA is expected to enhance their stability in hydro-
phobic polymer solution.
It is of great importance to increase the stability of SPIONs (Solid (S) phase) in PHBV–DCM solution (Oil 
(O) phase), because a stable S/O solution can reduce the loss of S phase during emulsification, which is a pre-
requisite to obtain a high encapsulation efficiency. In addition, a stable S/O droplet facilitates the production 
of more spherical shaped particles after solidification. As shown in Fig. 3(a), SPIONs0 sink to the bottom of the 
DCM, while SPIONsLA already partly disperse in the DCM even without sonication. After sonication (Fig. 3(b)), 
SPIONsLA are still stably present in the DCM, however most of the SPIONs0 were located in the water/DCM 
interface or inside the water. This result confirms that hydrophilic SPIONs0 turn hydrophobic after surface modi-
fication with lauric acid, which therefore enables the SPIONsLA to be stable in DCM, with the primary monolayer 
of lauric acid acting as the stabilizing layer34.
Composition of magnetic PHBV microspheres. The main composition of the pure PHBV microspheres 
(MS) and magnetic PHBV microspheres loaded with different content of SPIONsLA (MMSL (low content) and 
MMSH (high content)) was investigated by X-ray diffraction (XRD) analysis (Fig. 4(a)). All the samples showed 
characteristic peaks of PHBV at 13.5°, 16.9°, 19.9°, 21.6°, 22.8°, 25.6°, 27.2° and 30.8°35. Both MMSL and MMSH 
showed the characteristic peaks of Fe3O4 at 18.2°, 30.2°, 35.6°, 43.3°, 53.7°, 57.2° and 63.1°36, and the intensities of 
these peaks increased when the amount of loaded SPIONsLA was increased. The XRD patterns confirm that Fe3O4 
is successfully encapsulated in the PHBV microspheres.
The thermogravimetric behaviors of SPIONsLA and microspheres are shown in Fig. 4(b). The weight loss of 
SPIONsLA was mainly due to the decomposition of lauric acid. Compared to SPIONsLA, all the microspheres 
Figure 2. TEM images of SPIONsLA at different magnifications (a,b). The inset in (a) shows the particle size 
distribution of iron oxide cores.
Figure 3. Photos of SPIONs0 and SPIONsLA in water/DCM: (a) just after adding DCM and water, (b) 2 min 
after sonication.
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presented much higher weight loss due to the decomposition of PHBV. The thermogravimetric analysis (TGA) 
curves of the microspheres containing more SPIONsLA shifted towards higher temperature. This may be due to 
the increased thermal stability of PHBV-based nanocomposites in the presence of more nanoparticles35.
The loading efficiency of SPIONsLA in MMSL and MMSH was calculated to be 12.5 wt% and 20.3 wt%, and the 
encapsulation efficiency was 87.4% and 71.0%, respectively. The density of Fe3O4 (~5 g/cm3) is much higher than 
that of PHBV (~1.26 g/cm3) and DCM (~1.33 g/cm3). Therefore, more SPIONsLA loaded in the PHBV–DCM (i.e., 
higher loading efficiency) may increase the instability of the emulsion which eventually leads to more SPIONsLA 
been lost, i.e., lower encapsulation efficiency. SPIONs have been reported to be encapsulated in various polymer 
microspheres, while their encapsulation efficiency, as an important evaluation index of magnetic microsphere, 
has been reported in only few studies1,2,4,15,17,19,37. The encapsulation efficiency in the present study is similar to 
that (estimated to be ~65− 84%) of PLGA/PLA-PEG magnetic microspheres produced by O/W single emul-
sion method using hydrophobic magnetite gel as the magnetic component19, and is significantly higher than 
that (1.8− 4.5%) of hydrophilic ferrofluid loaded PLGA microspheres produced by conventional W/O/W double 
emulsion method2,4. In addition, the encapsulation efficiency achieved in this study is higher than that (60%) 
of hydrophilic F3O4 nanoparticles loaded PLA microspheres produced by a delicate W/O/W double emulsion 
method15.
Surface morphology and internal structure. The shape and surface morphology of the microspheres, as 
observed by scanning electron microscopy (SEM), are shown in Fig. 5. Both MMSL and MMSH appeared spheri-
cal in shape, and the microspheres had quite homogeneous particle size. Many SPIONsLA were seen to be embed-
ded into the surface of the microspheres. This phenomenon may be explained by the Pickering emulsion theory, 
specifically, iron oxide nanoparticles existed at the O/W interface to assist the surfactant to form a stable O/W 
emulsion11,29. The amount of loaded SPIONsLA seems to have no obvious influence on the surface morphology of 
the obtained microspheres. Furthermore, in order to reveal the internal structure, a cross-section near the center 
Figure 4. (a) XRD patterns and (b) TGA of MS (pure PHBV microspheres) and MMSL, MMSH (magnetic 
PHBV microspheres). TGA of SPIONsLA was performed for comparison.
Figure 5. SEM images of magnetic PHBV microspheres at different magnifications: surface morphology of 
(a,b) MMSL and (c,d) MMSH, and internal microstructure of (e,f) MMSH.
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of MMSH was obtained using focused ion beam (FIB) milling. As shown in Fig. 5(e,f), SPIONsLA are observed 
on the cross-section as well as on the wall of the inner pores of the microspheres. The pores inside the micro-
spheres are due to the fast skin formation during the solvent extraction, which restricts the further shrinkage/
densification of the microspheres during solidification20. The surface morphology and internal structure proves 
that SPIONsLA are distributed over the whole matrix of microspheres, which indicates that SPIONsLA are stable in 
PHBV–DCM solution and are efficiently encapsulated in the PHBV microspheres.
Particle size and zeta potential. The median particle size of both MMSL and MMSH was 2.46 μm 
(Fig. 6(a)). The span (width of particle size distribution) of MMSL and MMSH was 1.37 and 1.62, respectively. 
Different amounts of encapsulated SPIONsLA seem to have no obvious influence on the mean particle size of 
prepared microspheres, however higher amount of SPIONsLA slightly increased the microsphere size distribution 
width. The wider particle size distribution of MMSH can be attributed to the increased instability of the emulsion 
caused by loading of more SPIONsLA. Fig. 6(b) presents the zeta potential of SPIONsLA (− 19.9 mV) and micro-
spheres in water. The zeta potential of MS was − 33.6 mV, and it increased to − 28.1 mV for MMSL and further 
increased to − 22.8 mV for MMSH when more SPIONsLA were encapsulated. This phenomenon is due to the fact 
that the incorporated SPIONsLA possess a higher zeta potential than MS. The relatively high negative zeta poten-
tial of these microspheres is beneficial for their dispersion and stability in aqueous medium.
Magnetic properties. Fig. 7(a) shows the magnetization curves measured at room temperature for 
SPIONsLA, MMSL and MMSH. The saturation magnetization data obtained at high external field strength (2 T) 
are an approximation of the theoretical value of saturation magnetization. The magnetization curves, specially 
for MMSL and MMSH are only slightly increasing at 2 T, which means that the approximation is quite close to 
the theoretical value. The saturation magnetization values of MMSL and MMSH were 5.6 emu/g and 11.0 emu/g, 
respectively, and it was 56.8 emu/g for SPIONsLA. This behavior is more consistent with the saturation magneti-
zation of bulk maghemite (around 60 emu/g) than with the saturation magnetization of bulk magnetite (around 
Figure 6. (a) particle size distribution of MMSL and MMSH, (b) zeta potential of SPIONsLA, MS, MMSL and 
MMSH in water.
Figure 7. (a) magnetization curves measured at room temperature for SPIONsLA, MMSL and MMSH. The inset 
shows the response of MMSL and MMSH to a magnetic field. (b) T2-weighted MR images of H2O, 0.1 wt% agar 
solution and 0.25–2.0 mg/mL of MS, MMSL and MMSH dispersed in 0.1 wt% agar solution.
www.nature.com/scientificreports/
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90 emu/g)38. However, it has been shown earlier that dispersions of SPIONs are prone to oxidation during storage, 
which reduces the saturation magnetization significantly over time, e.g. by up to 28.9%39. Although the decrease 
in saturation magnetization could also derive from the smaller magnetic domain size of SPIONs compared to 
bulk material, it has been shown earlier that this is not the case for SPIONsLA24. Therefore it is likely that the 
particles had oxidized to maghemite already. The inset in Fig. 7(a) demonstrates the dispersion and separation 
process of the magnetic microspheres. Both MMSL and MMSH were well attractable with a magnet. Therefore, 
the prepared magnetic PHBV microspheres possessed magnet-induced sensitivity, and this ‘proof of concept’ 
experiment indicates that they could be utilized as magnetic targeting carriers in biomedical applications.
The prepared magnetic microspheres were qualitatively evaluated for their magnetic contrast capability under 
MRI scanning. T2-weighted MR images (Fig. 7(b)) show that MMSL and MMSH produced significant nega-
tive contrast effects (signal reductions) in comparison to the control groups, i.e., H2O, agar solution and MS in 
0.25–2.0 mg/mL. With increasing concentration of microspheres in agar solution, there was a corresponding 
increase in contrast for MMSL and MMSH. Furthermore, the contrast for MMSH was higher than MMSL at a 
same concentration due to the higher loading efficiency of SPIONsLA in MMSH. These results show that, although 
SPIONsLA are encapsulated in PHBV microspheres, they can still be used for magnetic imaging applications.
Drug release and antibacterial property. One of the purposes of this study was to determine if the 
magnetic PHBV microspheres could serve as potential vehicles to successfully deliver drugs. Fig. 8(a,b) shows the 
drug release profiles of SPIONsLA-TCH (TCH loaded SPIONsLA) loaded PHBV microspheres in PBS. Both MMSL 
and MMSH exhibited a sustained release of TCH for up to 14 days. Cumulative amounts of 101 μg and 168 μg 
TCH were released from MMSL and MMSH, respectively. The higher amount of TCH loading in MMSH could 
explain why it showed a slightly higher initial burst release followed by a relatively faster release at the initial stage 
compared to MMSL. The mass ratio of TCH in MMSH over that in MMSL is 1.66, which was quite close to the 
mass ratio (1.62) of the TCH carrier, i.e., SPIONsLA in MMSH over that in MMSL as determined by TGA. The 
adsorptive affinities of metal oxide nanoparticles for TCH are likely due to several mechanisms, including elec-
trostatic attraction, surface complexation and cation exchange40, while the exact mechanism in the present study 
is yet to be investigated. Phosphate ions exhibit high binding efficiency to the surface of iron oxides41, and can 
thus replace other substances such as drugs which are located on the surface of the SPIONs by the aforementioned 
mechanism. The fact that some, but not all of the drug is released via burst release could indicate a barrier effect 
of the polymer towards the drug loaded on iron oxide particles.
PHBV is hydrophobic42, and generally degrades quite slowly in vitro27. Therefore, the drug release from PHBV 
microspheres is likely to be more dependent on diffusion rather than on polymer degradation26,43,44. The drug 
release data was fitted to Higuchi equation45, and the results are shown in Fig. 8(c). The fitting for both MMSL and 
Figure 8. (a) Cumulative amount and (b) cumulative percentage of TCH release from MMSL and MMSH,  
(c) linear fitting of the cumulative percentage of TCH release versus the square root of time (Higuchi equation), 
and (d) antibacterial activity against Escherichia coli (E. coli) of diluted TCH solution collected at 1 h, 1 d, 3 d 
and 5 d.
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MMSH shows good linearity. Thus, TCH release from the magnetic PHBV microspheres can be well described by 
Higuchi equation, indicating a diffusion controlled release mechanism. In addition, MMSH had a higher kinetic 
constant (k) than MMSL, which confirms that the TCH release from MMSH was faster than from MMSL in the 
first 24 hours (as shown in Fig. 8(b)).
In order to better differentiate the antibacterial property of TCH solution collected at 1 h, 1 d, 3 d and 5 d 
during drug release, the solutions were diluted in different ratios. Repetition of the antibacterial test is needed for 
performing statistical analysis in further study, while the bacterial growth for both MMSL and MMSH (Fig. 8(d)) 
exhibits an overall decreasing trend when the drug release time increases from 1 h to 5 d, indicating increasing 
TCH concentration. Moreover, at a given time point, MMSH in general showed less bacterial growth than MMSL, 
which confirms MMSH released more TCH than MMSL, as shown in Fig. 8(a). Hence, the results of the prelimi-
nary antibacterial tests are in good agreement with the results of drug release study and confirm the drug delivery 
capability of the prepared magnetic PHBV microspheres.
In vitro cytotoxicity. Jurkat T cells (suspension cells) and HT-29 colon carcinoma cells (adherent cells) 
were used to investigate the biocompatibility of PHBV microspheres (without TCH) in various concentrations. 
After 24 h and 48 h of incubation, cells were stained and analyzed in flow cytometry. Staining with the DNA 
dye Hoechst and differences in size enabled the clear discrimination between cells and microspheres. Using 
the cyanine dye DiIC1(5) (1,1′ ,3,3,3′ ,3′ -hexamethylindodicarbocyanine iodide), we stained cells with an active 
mitochondrial membrane potential (MMP) as a measure for intact cell metabolism. Decrease of DiIC1(5) stain 
intensity indicates a disrupted mitochondrial membrane potential. Data were confirmed by AnnexinA5-FITC /
propidium iodide staining (not shown), which detects exposure of phosphatidylserine on the outer side of the 
plasma membrane of apoptotic cells and disrupted plasma membranes of necrotic cells, respectively. Investigating 
the side scatter (SSC) of viable cells as mean of cellular granularity indicates a concentration dependent cellular 
uptake of the microspheres after 24 h, whereas after 48h, the SSC values have equaled for all tested concentrations 
of each microsphere indicating a saturation effect (Fig. 9(a)). The cellular proliferation was dose dependently 
decreased by the presence of microspheres in Jurkat cells (Fig. 9(b)). In contrast, cell viability, reflected by intact 
MMP (Fig. 9(c)) and DNA integrity (Fig. 9(d)), were only slightly influenced in Jurkat cells by the microspheres, 
indicating their biocompatibility even in high concentrations and prolonged incubation times. AnnexinA5-FITC/
propidium iodide staining confirmed these results (data not shown). In addition, due to their relatively large 
particle size, microspheres gradually sedimented, thus at the bottom of the cell culture wells locally even higher 
microsphere concentrations can be assumed. Therefore, microsphere concentrations are given in both μg/mL 
and μg/cm2.
Figure 9. Biocompatibility of MS, MMSL and MMSH on Jurkat T cells. Experiments were performed in 
triplicates. Results are given as mean ± standard deviations (The asterisks indicate significant differences in 
Student’s t-test compared to the controls *P < 0.05, **P < 0.01). Experiments were performed in 48 well plates 
(growth area of 1 cm2/well) and 1 mL medium. Microsphere concentrations are given in mg/mL and mg/cm2. 
(a) SSC increase of viable cells (gated on DiIC1(5) positive cells) reflects microsphere uptake by cells; t = 24 h 
and 48 h, (b) relative viable cell count indicates reduced cellular proliferation caused by microspheres; t = 48 h, 
(c) DiIC1(5) staining provides information about MMP. DiIC1(5) positive cells have an intact MMP and can be 
considered viable; whereas DiIC1(5) negative cells can be considered dying/dead; t = 48 h, (d) PI-triton staining 
shows that cell cycle and DNA integrity is not influenced by microspheres; t = 48 h.
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HT-29 colon carcinoma cells (adherent cells) were incubated with 0.5 mg/mL (56 μg/cm2) or 2 mg/mL (224 μg/cm2) 
microspheres (Fig. 10). After 24 h of incubation, transmission microscope images (Fig. 10(a,b)) showed that 
adherent cells were still tightly attached to the plastic surfaces of the wells and looked phenotypically healthy even 
in the presence of high microsphere concentrations (Fig. 10(b)). For more detailed investigation, flow cytometry 
of HT-29 cells was performed after trypsin detachment and staining with DiIC1(5) (Fig. 10(c)). As shown by mor-
phological analysis and investigation of mitochondrial membrane potential, incubation with 0.5 mg/mL (56 μg/
cm2) microspheres induced only a slight loss in cell viability (Fig. 10(d)).
Altogether, cell viability in the presence of MMSL, MMSH as well as MS was better than free SPIONsLA at a 
comparable concentration as shown in the related previous study24, therefore we conclude that encapsulation of 
SPIONsLA in PHBV microspheres improved their biocompatibility. The biocompatibility of these magnetic PHBV 
microspheres ensures their potential for use in biomedical applications such as drug delivery and MRI.
Conclusions
SPIONs after surface modification with lauric acid became much more stable in DCM solution, which therefore 
allowed the preparation of magnetic SPION-containing PHBV microspheres with high encapsulation efficiency 
(71.0–87.4%) using emulsion-solvent extraction/evaporation method. The obtained microspheres appeared 
spherical in shape, and had a median particle size of 2.46 μm. SPIONsLA were observed throughout the matrix 
of microspheres. Loading efficiencies of the microspheres were determined to be 12.5–20.3 wt%, and the cor-
responding magnetization was 5.6–11.0 emu/g. The zeta potential of the microspheres increased but it was still 
negative with increasing content of encapsulated SPIONsLA. The developed magnetic PHBV microspheres were 
readily detectable by MRI, and increasing contrast was observed for the microspheres loaded with higher content 
of SPIONsLA. The magnetic PHBV microspheres were shown to be biocompatible towards both Jurkat cells (sus-
pension cells) and HT-29 cells (adherent cells) even at high concentrations. TCH, as a model drug, was success-
fully loaded into the microspheres, and released in a diffusion controlled manner. The developed magnetic PHBV 
microspheres have potential applications in targeted drug delivery and MRI.
Figure 10. Biocompatibility of MS, MMSL and MMSH on adherent HT-29 cells. Experiments were 
performed in triplicates, shown are the mean values with standard deviations. HT-29 cells were seeded into 
cell culture wells (6 well plates; growth area 8.9 cm2, 1 mL medium), grown for 24 hours and incubated with 
microspheres for 24 h. (a,b) Transmission microscope images (magnification 10× ) of HT-29 cells incubated 
with (a) 0.5 mg/mL microspheres or (b) 2 mg/mL microspheres for 24 h. (c) Flow cytometry raw data file 
(Forward scatter versus side scatter) depicts possibility to discriminate between microspheres (red), viable 
(green) and dying/dead cells (blue) by morphological parameters; (d) analysis of cell viability by morphology 
and mitochondrial membrane potential. Viability of control cells was set to 100%; experiment was performed in 
triplicates; shown are the mean values with standard deviations.
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Materials and Methods
Materials. PHBV with a PHV content of 12 wt% was purchased from Goodfellow (Huntingdon, UK). 
Polyvinyl alcohol (PVA) (MW ~30,000), Ringer´s solution and Iron (II) chloride tetrahydrate were from Merck 
(Darmstadt, Germany). DCM, propidium iodide (PI), sodium citrate, triton X-100, acetone and lauric acid were 
obtained from Sigma-Aldrich (St. Louis, USA). Ammonia solution 25% and Iron (III) chloride hexahydrate were 
supplied by Roth (Karlsruhe, Germany). TCH was purchased from AppliChem (Darmstadt, Germany). RPMI 
1640 medium, fetal calf serum (FCS), Annexin A5-FITC (Ax), Hoechst 33342 (Hoechst) and DiIC1 (5) were 
acquired from Thermo Fisher Scientific (Waltham, USA).
Preparation of SPIONs and lauric acid-coated SPIONs. Uncoated SPIONs (SPIONs0) and lauric 
acid-coated SPIONs (SPIONsLA) were synthesized as described in detail elsewhere25. In brief, 1.998 g of iron 
(II) chloride tetrahydrate and 5.406 g of iron (III) chloride hexahydrate were dissolved in 20 mL of ultrapure 
water under Ar atmosphere and heated to 80 °C. 16.5 mL ammonia solution (25%) were added to form a blackish 
precipitate of SPIONs0. To obtain SPIONsLA, 1.28 g of lauric acid dissolved in acetone were added after that and 
the suspension was heated to 90 °C for another 15 minutes. Both particle suspensions were purified by dialysis 
using a molecular weight cut off of 8000 Da and the pH was adjusted to 9.2 using ammonia solution. They were 
lyophilized and stored at 4 °C until further use.
Characterization of SPIONsLA. FTIR measurement. The chemical composition of the lyophilized nan-
oparticles was determined using FTIR (Nicolet 6700, Thermo Scientific, USA). The sample was mixed with KBr 
(spectroscopy grade, Merck, Germany) and pressed into pellets. Spectra were recorded in absorbance mode 
between 4000 and 400 cm−1 with a resolution of 4 cm−1.
Stability of SPIONsLA. 5 mg SPIONs0 and SPIONsLA were placed in a glass vial, respectively. 2 mL DCM were 
added into the glass vial followed by adding 4 mL water. Photos were taken immediately after adding the water. 
Afterwards, the mixture was homogenized by a probe sonicator (Branson Sonifier® S-250D, Emerson, USA) at 
10% power output for 40 s. Photos were taken 2 min after the sonication. 2 min was chosen here because this is the 
emulsification time for preparing PHBV microspheres in the following study.
TEM. TEM images were taken with a CM 300 UltraTWIN (Philips, Eindhoven, Netherlands) operated at an 
acceleration voltage of 300 kV. Samples were prepared by drying 10 μL of diluted nanoparticle suspension on a 
carbon-coated Athene S147-2 copper grid (Plano, Wetzlar, Germany). Particle size distribution of the iron oxide 
cores was determined using Image J (NIH, USA), and more than 100 particles were analyzed.
Preparation of magnetic PHBV microspheres. A solid-in-oil-in-water (S/O/W) emulsion-solvent 
extraction/evaporation method was used to prepare the magnetic PHBV microspheres by modifying the method 
used in our previous study43. Briefly, SPIONsLA (S phase) were added into 3 mL of 3% w/v PHBV–DCM solution 
(O phase). Two mass ratios of SPIONsLA to PHBV were chosen, i.e., 1:6 (MMSL) and 1:2.5 (MMSH). The mix-
ture was homogenized by a probe sonicator at 10% power output for 40 s. Then, the homogeneous mixture was 
added into 75 mL of 2% w/v PVA solution (W phase) and emulsified using a homogenizer (T18, IKA, Germany) 
at 10500 rpm for 2 min. Afterwards, the obtained emulsion was added into 225 mL of 1% w/v PVA solution. The 
final solution was stirred at 600 rpm for 2 h by an over-head stirrer (Eurostar 20, IKA, Germany) to evaporate the 
organic solvent. The microspheres were collected by centrifugation (Centrifuge 5430R, Eppendorf, Germany) at 
5000 rpm for 4 min, washed in deionized water, and lyophilized (Alpha 1-2 LDplus, Martin Christ, Germany). 
The microspheres were stored in a desiccator until further use. Pure PHBV microspheres were prepared following 
the procedure described above, except that no SPIONsLA were added into the PHBV solution.
Characterization of magnetic PHBV microspheres. Surface morphology and internal microstructure. 
Surface morphology was observed using SEM (LEO 435 VP, Cambridge, UK and Ultra Plus, Zeiss, Germany). 
Dried microspheres were mounted onto stubs using carbon tapes. No metallic coating was applied on the 
microspheres for SEM observation. The cross-sections of single microsphere were obtained using a FIB (Helios 
NanoLab™ 660, FEI, Hillsboro, USA). The microspheres were sputter coated first with 200 nm thick carbon, 
then with 2 μm thick platinum. A Ga+ beam of 30 kV between 40 and 90 pA was used to cut the microspheres. 
Once the samples had been polished to the desired cross-sections, SEM images were taken in secondary electron 
imaging mode.
Particle size and zeta potential. Particle size and zeta potential of the microspheres were analyzed by Mastersizer 
particle size analyzer 2000 and Malvern Zetasizer Nano ZS (Malvern, Worcestershire, UK), respectively. For these 
measurements, microspheres were suspended in deionized water. In addition to the median particle size (D50), 
the width of particle size distribution (span) was also calculated. The span is calculated by (D90− D10)/D50, where 
Di means i% of the particle distribution lies below the size Di.
Encapsulation efficiency and loading efficiency. The encapsulation efficiency and loading efficiency of SPIONsLA 
in magnetic PHBV microspheres were determined by TGA (Q5000, TA Instruments, USA). The samples were 
heated from 25 °C to 550 °C under nitrogen flow. The heating rate was 10 °C/min. The loading efficiency and 
encapsulation efficiency were calculated by equations (1) and (2), respectively:
= ×Loading efficiency Mass of SPIONs in microspheres/Mass of microspheres 100% (1)LA
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=
×
Encapsulation efficiency Mass of SPIONs in microspheres/Mass of SPIONs
used for preparing microspheres 100% (2)
LA LA
Magnetic properties (SQUID and MRI). The magnetic properties of the samples in solid form (lyophilized 
powder) were measured using a superconducting quantum interference device (SQUID)-based susceptometer 
(QD-MPMS-XL-5, Quantum Design Inc, San Diego, USA) in an applied magnetic field of ± 2 T at room temper-
ature. The sample holder used for the measurement was gelatin capsule. Diamagnetic contribution of the sample 
holder was subtracted. The obtained magnetization is given in emu per gram (of total material). MRI studies were 
conducted on a 3T Siemens Trio-Tim scanner (Siemens, Erlangen, Germany). Imaging phantoms were prepared 
by dispersing microspheres in 0.1 wt% agar solution at 0.25–2.0 mg/mL.
XRD analysis. The main composition of the microspheres was characterized using XRD (Bruker D8 ADVANCE 
Diffractometer, Cu Kα) at room temperature. Data were collected over the 2θ range from 10° to 70° using a step 
size of 0.014° with 1 second per step.
In vitro drug release study. Drug loading. SPIONsLA were soaked in 3 mg/mL TCH–deionized water 
solution for 24 h. Then, the TCH loaded SPIONsLA (SPIONsLA-TCH) were collected by centrifugation, washed in 
deionized water, and lyophilized. The loading degree of TCH on SPIONsLA was 8.8 wt%. SPIONsLA-TCH loaded 
PHBV microspheres were prepared following the same procedure as SPIONsLA loaded PHBV microspheres. The 
drug loading and drug release process were kept off light.
Drug release. 10 mg MMSL and MMSH were dispersed in 1 mL PBS solution (pH 7.4) and placed in a dialysis 
bag (Spectra/Por® 1, molecular weight cut-off 6000 to 8000, Carl Roth, Germany), and then immersed in tubes 
containing 4 mL PBS solution (pH 7.4). The samples were placed in a shaking incubator (90 rpm, 37 °C). After 
predetermined time points, 1 mL medium was collected and replaced with 1 mL fresh PBS solution. TCH concen-
tration was measured using a UV–Vis spectrophotometer (Specord® 40, Analytik Jena, Germany) at a wavelength 
of 362 nm. A calibration curve was made with TCH concentration in the range 2.5–100 μg/mL, and the obtained 
calibration curve follows Beer’s law: A = 0.0294 × C, where A is the absorbance and C is the concentration of 
TCH. The cumulative release (%) of TCH was calculated. The drug release study was carried out for 408 h and 
performed in triplicate.
Drug release kinetics. Higuchi model was used to analyze the TCH release kinetics from the magnetic PHBV 
microspheres, which is represented by equation: Qt = kt1/2, where Qt is the cumulative percentage of drug release, 
k is the kinetic constant and t is the release time45. This equation is generally valid for the first 60% of total amount 
of drug release.
Antibacterial test. 4 mg MMSL and MMSH were placed in a dialysis bag, respectively, and then immersed in 
2 mL PBS solution. 100 μL released medium was collected at 1 h, 1 d, 3 d and 5 d, and diluted in 10 mM sterilized 
sodium phosphate buffer for antibacterial test. TCH concentration in the released medium was measured using a 
UV–Vis spectrophotometer. Antibacterial activities of the diluted medium were evaluated using the 96-well plate 
assay46. E. coli ATCC 25922 was purchased from Leibniz Institute DSMZ-German Collection of Microorganisms 
and Cell Cultures (Braunschweig, Germany). E. coli were inoculated into fresh nutrient broth (Roth, Karlsruhe, 
Germany) and incubated at 37 °C for 8 h with shaking to reach the logarithmic phase of growth at a density of 
1–5 × 107 cfu/mL. Then, these bacterial suspensions were diluted to a density of 1–2 × 105 cfu/mL. Individual 
wells of a sterilized 96-well microtitre plate were inoculated with 50 μL of samples, i.e., diluted medium and 50 μL 
of bacterial suspension. Control wells contained all the components except the samples, which were replaced by 
50 μL ampicillin solution of 10 μg/mL (positive control) or 50 μL sterilized sodium phosphate buffer of 10 mM 
(negative control). The 96-well plates were incubated overnight at 37 °C with shaking. The experiment was con-
ducted in duplicates and the optical density at 600 nm was spectrophotometrically recorded after the incubation 
by using a temperature-controlled automatic plate reader (Tecan, Männedorf, Switzerland). Percentage of bacte-
rial growth (Pbacterial growth) was determined by
− − × .( ) ( )OD OD OD OD/ 100%sample positive control negative control positive control
In vitro biocompatibility assays. The non-adherent human T-cell leukemia cell line Jurkat (ACC 282, 
DSMZ, Braunschweig, Germany) was cultured in RPMI 1640 medium supplemented with 10% FCS. Adherent 
colon carcinoma HT-29 cells (ATCC/LGC GmbH, Wesel, Germany) were cultured in McCoy’s 5A medium 
(Gibco®, Life Technologies GmbH, Darmstadt, Germany) supplemented with 10% FCS. All cells were cultivated 
under standard cell culture conditions in a humidified incubator (INCOmed, Schwabach, Memmert, Germany) 
at 37 °C and 5% CO2.
Prior to these experiments, viability and count of cells were determined using a Muse cell analyzer (Merck 
Millipore, Darmstadt, Germany). Only if the viability exceeded 90% the experiments were continued. The micro-
spheres were sterilized under UV light for 2 h.
Jurkat cells were adjusted to 2 × 105 cells/mL in medium. 1 mL of this suspension, containing the respective 
concentration of microspheres (without TCH), was seeded into 48 well plates (Greiner Bioone, Frickenhausen, 
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Germany). After 24 h and 48 h, 50 μL aliquots of the cells and microspheres containing suspension were taken and 
stained for cell viability analysis.
3.4 × 105 HT-29 cells were seeded into each well of a 6 well plate (TPP, Schaffhausen, Switzerland) in medium, 
grown for 24 h and incubated in the presence of microspheres for further 24 h. Then, transmission optical micros-
copy was performed using an Axiovert 40 CFL Microscope (Zeiss, Jena, Germany) with a 10x objective with 
phase contrast. Then, cells were detached with 0.25% trypsin/0.02% EDTA in PBS (PAN Biotech, Aidenbach, 
Germany) from the wells and resuspended to form single-cell suspensions.
Since microspheres gradually sediment to the bottom of the cell culture wells, indication of microsphere con-
centration in μg/mL and μg/cm2 is required (see Table 1).
Analyses for cell viability were then performed according to a protocol from Munoz et al.47. For staining, 
250 μL of the staining solution (containing 20 μg/mL PI, 0.5 μg/mL Annexin A5-FITC, 10 nM DiI and 1 μg/mL 
Hoechst 33342 in Ringer´s solution) were added to cell aliquots and incubated for 20 min at 4 °C. The suspensions 
were then analyzed with a Gallios flow cytometer (Beckman Coulter, Fullerton, USA) for 1 min. Bleed through 
fluorescence was eliminated by electronic compensation. Forward scatter (FSC) and side scatter (SSC) were 
considered for morphological analysis of cells. Cell cycle and DNA degradation were examined by propidium 
iodide-triton (PIT) staining according to the protocol of Nicoletti et al.48. Briefly, 400 μL of a solution containing 
0.1% sodium citrate, 0.1% Triton X-100, and 50 μg/mL PI was added to 50 μL aliquot of cells, incubated overnight 
at 4 °C in the dark, and nuclear fluorescence was measured in flow cytometry. Data analysis was performed with 
the software Kaluza 1.2.
Statistical analysis. Statistical significance analysis was performed using Student’s t-test in Microsoft Excel 
2010 (Microsoft, Redmond, USA). A value of P < 0.05 was considered statistically significant.
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